Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...

There were 27 new measles infections from a Spartanburg County church and schools, sending the outbreak there to 111 cases, ...

This guidance should be used alongside the following resources: Measles is highly infectious and has multiple differential ...

Total Outbreaks + National Share: Vermont reported 100 norovirus outbreaks over the past decade, accounting for 0.5% of all U ...

Cases of serious food poisoning linked to Listeria bacteria rose in Europe last year, likely fuelled by changing diets and an ...

Teclistamab-cqyv plus subcutaneous daratumumab significantly improved OS and PFS in relapsed/refractory multiple myeloma compared to standard regimens, reducing death risk by 54%. The combination ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or ...

ORLANDO, Dec. 9, 2025) Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal ...

Jaypirca significantly improved progression-free survival in treatment-naive CLL/SLL, reducing disease progression or death risk by 80% compared to BR. The 24-month progression-free survival rate was ...

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line[1] Data ...